Lomitapide: a novel drug for homozygous familial hypercholesterolemia-Reference-Cited by-同舟云学术

Lomitapide: a novel drug for homozygous familial hypercholesterolemia

Published:2014-02-01 Issue:1 Volume:9 Page:19-32
ISSN:1758-4299
Container-title:Clinical Lipidology
language:en
Short-container-title:Clinical Lipidology

Author:

Panno Maria D¹,Cefalù Angelo B¹,Averna Maurizio R¹

Affiliation:

1. Dipartimento Biomedico di Medicina Interna e Specialistica, Policlinico ‘Paolo Giaccone’, University of Palermo, Via del Vespro 141, 90127 Palermo, Italy

Publisher

Informa UK Limited

Subject

Cardiology and Cardiovascular Medicine,Endocrinology, Diabetes and Metabolism

Link

https://www.tandfonline.com/doi/pdf/10.2217/clp.13.74

Reference61 articles.

1. Lomitapide. Am. J. Cardiovasc. Drugs 11(5), 347–352 (2011).

2. Innerarity TL, Weisgraber KH, Arnold KS et al. Familial defective apolipoprotein B‑100: low density lipoproteins with abnormal receptor binding. Proc. Natl Acad. Sci. 84(19), 6919–6923 (1987).

3. Abifadel M, Varret M, Rabes JP et al. Mutations in PCSK9 cause autosomal dominant hypercholesterolemia. Nat. Genet. 34(2), 154–156 (2003).

4. Goldstein JL, Hobbs HH, Brown MS et al. Familial Hypercholesterolemia. In: The Methabolic and Molecular Bases of Inherited Disease (8th Edition). Scriver CR (Ed.). Mc Graw‑Hill, NY, USA, 2863–2913 (2001).

5. Pisciotta L, Priore Oliva C, Pes GM et al. Autosomal recessive hypercholesterolemia (ARH) and homozygous familial hypercholesterolemia (FH): a phenotypic comparison. Atherosclerosis 188(2), 398–405 (2006).

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. In vitro to in vivo extrapolation and high-content imaging for simultaneous characterization of chemically induced liver steatosis and markers of hepatotoxicity;Archives of Toxicology;2023-04-12

2. Description and in silico ADME studies of US-FDA approved drugs or drugs under clinical trial which violate the Lipinski’s rule of 5;Letters in Drug Design & Discovery;2023-02-24

3. A decade of approved first-in-class small molecule orphan drugs: Achievements, challenges and perspectives;European Journal of Medicinal Chemistry;2022-12

4. Chemical screening of food-related chemicals for human fatty liver risk: Combining high content imaging of cellular responses with in vitro to in vivo extrapolation;2022-06-03

5. Therapeutic Options for Homozygous Familial Hypercholesterolemia: The Role of Lomitapide;Current Medicinal Chemistry;2020-07-01